Researchers have found a small molecule enzyme inhibitor capable of manipulating an immune process that plays an important role in cancers and autoimmune diseases. Researchers at the University of ...

A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

Researchers at the University of Illinois Chicago have found a small molecule capable of manipulating an immune process that plays an important role in cancers and autoimmune diseases. Their discovery ...

Consuming too much added sugar can increase the risk of chronic diseases such as Type 2 diabetes, heart disease, obesity, non-alcoholic fatty liver disease, high blood pressure and some cancers, ...

BOSTON - Researchers at Beth Israel Deaconess Medical Center (BIDMC) have identified an enzyme that is significantly elevated in mouse models of systemic lupus erythematosus and in blood samples of ...

Sanofi’s rare disease programs are racking up speedy review tags. After scoring breakthrough and fast-track status from the FDA, the French pharma’s Pompe disease treatment grabbed a priority review ...

-- With nanomolar potency against SARS-CoV-2, ASLAN003 is also being assessed for its potential as a novel therapeutic for COVID-19 and other viruses SINGAPORE, Oct. 16, 2020 (GLOBE NEWSWIRE) -- ASLAN ...

– Preclinical data demonstrate MALT1 inhibitors effectively target the anabolic hub to modulate key drivers of autoimmune and inflammatory diseases – – Bioinformatic data confirm metabolic pathway ...

Researchers at the University of Illinois Chicago have found a small molecule capable of manipulating an immune process that plays an important role in cancers and autoimmune diseases. Their discovery ...